ERYTech Pharma SA Sponsored ADR Aktie News

Lyon (France), June 23, 2023 – ERYTECH Pharma (Euronext Paris & Nasdaq: ERYP) announced today that all resolutions for which the Board of Directors recommended a vote in favor, including the approval of the merger with Pherecydes, were adopted by its shareholders at the Combined General Meeting that was held today, June 23, 2023.

Erytech Pharma SA (NASDAQ:ERYP ) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Gil Beyen - CEO Thibaut du Fayet - CEO, Pherecydes Pharma Didier Hoch - Chairman, Pherecydes Pharma Conference Call Participants Jacob Mekhael - Kempen & Co. Operator Thank you for standing by, and welcome to the conference call on the proposed merger between ERYTECH Pharma and Pherecy...

ERYTECH Pharma S.A. (NASDAQ:ERYP ) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET Company Participants Gil Beyen - CEO Eric Soyer - CFO and COO Conference Call Participants Boris Peaker - Cowen Operator Good morning, and thank you for standing by.

ERYTECH Pharma S.A. (NASDAQ:ERYP ) Q2 2022 Results Conference Call September 13, 2022 8:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial and Chief Operating Officer Dr. Iman El-Hariry - Chief Medical Officer Conference Call Participants Jacob Mekhael - Kempen Operator Good day, and thank you for standing by.

ERYTECH Pharma S.A. (NASDAQ:ERYP ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Gil Beyen – Chief Executive Officer Eric Soyer – Chief Financial and Chief Operating Officer Dr. Iman El-Hariry – Chief Medical Officer Conference Call Participants Boris Peaker – Cowen and Company Jacob Mekhael – Kempen & Co Operator Good day, and thank you for standing by.

Here's what you need to know about trading penny stocks on April 25th The post Best Penny Stocks to Buy as April Ends? 3 to Watch Today  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q4 2021 Results - Earnings Call Transcript

The stock price of Erytech Pharma SA (NASDAQ: ERYP) increased by over 40% pre-market today. This is why it happened.The stock price of Erytech Pharma SA (NASDAQ: ERYP) increased by over 40% pre-market today.